ScreenerHero

DWTX Dogwood Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · dwtx.com
1.430USD-5.92%Mkt Cap: 48.61M $P/E: 0.65

Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders. Its lead product candidates include IMC-1, a combination of famci…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap48.61M USD
Enterprise Value42.19M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-34.26M USD
Revenue/Share—
Last Price1.430 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees8
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)0.65
P/E (Forward)-0.24
PEG—
EV/EBITDA-1.43
EV/Revenue—
P/S—
P/B0.75
EPS (TTM)2.19
EPS (Forward)-6.37
52W Range
1.2802% of range9.500
52W High9.500 USD
52W Low1.280 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-45.74%
ROA-37.99%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-15.62M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-33.66%
Net Debt-9.48M USD
Net Debt/EBITDA0.32
Balance Sheet
Debt/Equity0.00
Current Ratio3.89
Quick Ratio3.39
Book Value/Sh2.03 USD
Cash/Share0.28 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateOct 9, 2024
Analyst Consensus
Rating—
Target (Mean)14.00 USD
Upside (mean)+879.0%
Target Range12.00 USD – 15.00 USD
12.00+879.0% to mean15.00
# Analysts3
Ownership
Shares Out.33.99M
Float5.81M
Insiders72.57%
Institutions11.47%
Short Interest
Short Ratio0.9d
Short % Float0.61%
Short % Out.0.22%
Shares Short74.27K
Short (prev mo.)49.96K
Technical
SMA 501.907 (-25.0%)
SMA 2002.253 (-36.5%)
Beta1.94
S&P 52W Chg16.45%
Avg Vol (30d)76.57K
Avg Vol (10d)60.88K
Technical Indicators
RSI (14)35.7
MACD-0.1410
MACD Signal-0.1367
MACD Hist.-0.0043
BB Upper2.045 USD
BB Middle1.595 USD
BB Lower1.144 USD
BB Width56.47%
ATR (14)0.1663 USD
Vol Ratio (20d)0.64x